CLINICAL_TRIALS
trial_result
· 2024-03-12
Clinical Trial Update: Safety and Effectiveness of Nintedanib in Korean Patients
Summary
Clinical trial update on safety and effectiveness of nintedanib in Korean patients with idiopathic pulmonary fibrosis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Idiopathic Pulmonary Fibrosis | Status: COMPLETED | Results posted: 2024-03-12